A polyacetylene compound from herbal medicine regulates genes associated with thrombosis in endothelial cells.

[1]  F. Cipollone,et al.  COX-2: friend or foe? , 2007, Current pharmaceutical design.

[2]  J. Whitelock,et al.  Perlecan: how does one molecule do so many things? , 2006, Cellular and Molecular Life Sciences CMLS.

[3]  Angelika Brekman,et al.  Rediscovery of natural products using genomic tools. , 2006, Bioorganic & medicinal chemistry letters.

[4]  Jing-ping Ou-yang,et al.  Pharmacological actions of sodium ferulate in cardiovascular system. , 2006, Cardiovascular drug reviews.

[5]  R. Medcalf,et al.  The undecided serpin , 2005, The FEBS journal.

[6]  Masahiro Yamamoto,et al.  The effect of herbal medicine Toki-shakuyaku-san on blood pressure in an Nomega-nitro-L-arginine methyl ester-induced pre-eclampsia rat model during pregnancy and the postpartum period. , 2005, Journal of pharmacological sciences.

[7]  L. Lau,et al.  Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells. , 2004, Blood.

[8]  M. Aburada,et al.  The herbal medicine Toki-shakuyaku-san improves the hypertension and intrauterine growth retardation in preeclampsia rats induced by Nomega-nitro-L-arginine methyl ester. , 2004, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[9]  Jun Wang,et al.  DNA microarray for identification of the herb of dendrobium species from Chinese medicinal formulations. , 2003, Planta medica.

[10]  N. Iizuka,et al.  Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray , 2003, International journal of cancer.

[11]  A. Sinskey,et al.  Gene expression changes in the human fibroblast induced by Centella asiatica triterpenoids. , 2003, Planta medica.

[12]  H. Cheung,et al.  Pyranocoumarins isolated from Peucedanum praeruptorum as differentiation inducers in human leukemic HL-60 cells. , 2003, Planta medica.

[13]  P. Schultz,et al.  Transcriptional Effects of the Potent Enediyne Anti-Cancer Agent Calicheamicin γ1I , 2002 .

[14]  W. Yan,et al.  Anti-thrombosis effect of paeoniflorin: evaluated in a photochemical reaction thrombosis model in vivo. , 2001, Planta medica.

[15]  T. Tanaka.  Effects of herbal medicines on menopausal symptoms induced by gonadotropin-releasing hormone agonist therapy. , 2001, Clinical and experimental obstetrics & gynecology.

[16]  C. Lindoff,et al.  Significance of the Plasminogen Activator Inhibitor of Placental Type (PAI-2) In Pregnancy , 1998, Seminars in thrombosis and hemostasis.

[17]  A. Matsuki,et al.  Analgesic effect of a herbal medicine for treatment of primary dysmenorrhea--a double-blind study. , 1997, The American journal of Chinese medicine.

[18]  J. Gilabert,et al.  Decreased Expression of PAI-2 mRNA and Protein in Pregnancies Complicated with Intrauterine Fetal Growth Retardation , 1996, Thrombosis and Haemostasis.

[19]  M. Baker,et al.  Biological and clinical aspects of plasminogen activator inhibitor type 2. , 1995, Blood.

[20]  Y. Kano,et al.  Effects of the acetylene compound from Atractylodes rhizome on experimental gastric ulcers induced by active oxygen species. , 1994, Biological & pharmaceutical bulletin.

[21]  J. Gilabert,et al.  Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation. , 1994, Gynecologic and obstetric investigation.

[22]  Y. Kano,et al.  Enzyme inhibitory activities of acetylene and sesquiterpene compounds in atractylodes rhizome. , 1993, Biological & pharmaceutical bulletin.

[23]  J. Gilabert,et al.  Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia. , 1991, American journal of obstetrics and gynecology.

[24]  Y. Kano,et al.  A New Polyacetylene Compound from Atractylodes Rhizome , 1989 .